Clinical Trial Update: A Study to Test the Efficacy and Safety of Bimekizumab and Certolizumab Pegol in Patients With Active Ankylosing Spondylitis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bimekizumab and certolizumab pegol in active ankylosing spondylitis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• Bimekizumab (bimekizumab)
• Certolizumab pegol (certolizumab pegol)

Snippet

Sponsor: UCB Biopharma SRL | Conditions: Ankylosing Spondylitis | Phase 2 | Status: COMPLETED | Results posted: 2023-07-27